Yongjae Yoo

Dr. Yongjae Yoo

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YYYongjae Yoo
Yongjae Yoo
CLChang-Soon Lee
Chang-Soon Lee
YKYong-Chul Kim
Yong-Chul Kim
JMJee Youn Moon
Jee Youn Moon
RFRoderick J. Finlayson
Roderick J. Finlayson
Background: Because it affords greater accuracy than landmark-based techniques, ultrasound guidance may reduce the volume of local anesthetic required for sympathetic blockade of the upper extremity. We hypothesized that 4 mL would provide a similar clinical effect when compared to larger volumes. Methods: One hundred and two patients with chronic neuropathic pain of the upper extremity or face were randomly assigned to receive an ultrasound-guided (USG) stellate ganglion block (SGB) with either 4 mL (group A), 6 mL (group B) or 8 mL (group C) mL of 1.0% lidocaine. Skin temperatures of the face, hand, and axillary fold were measured bilaterally at baseline, 10, 20, and 30 min after the block. Our primary outcome was the relative increase in hand temperature on the blocked side at 30 min and our non-inferiority margin was −0.6 °C. Secondary outcomes included success rate (as defined by a relative temperature increase of ≥1.5 °C), pain relief, degree of ptosis and side-effects. Results: The 95% confidence intervals for the difference of the means exceeded our non-inferiority margin (A versus B: −0.76 to 0.24; A versus C: −0.89 to 0.11) for temperature changes in the hand; however, success rates were similar (44, 45 and 55% for A, B and C respectively, p = 0.651). No intergroup differences were found in temperature-related outcomes for the other measurement sites (face, axilla). The incidence of minor side-effects was significantly higher in group C and no block-related complications were noted. Conclusions: We were unable to establish the non-inferiority of a 4 mL volume for sympathetic blockade of the hand. The clinical significance of these findings is unclear as success rates were similar between the different groups. In contrast, the 6- and 8 mL volumes were not associated with greater temperature changes in the face and axilla.

1 December 2020 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
JKJeongsoo Kim
Jeongsoo Kim
HLHo-Jin Lee
Ho-Jin Lee
YLYoung-Ju Lee
Young-Ju Lee
CLChang-Soon Lee
Chang-Soon Lee
YYYongjae Yoo
Yongjae Yoo
JMJee Youn Moon
Jee Youn Moon
Purpose: Ultrasound-guided thoracic paravertebral block (US-TPVB) is considered a treatment option for the management of acute pain in various pain-related conditions. We conducted a prospective pilot study to evaluate the possibility of US-TPVB as a sympathetic blockade in patients with neuropathic pain disorders in the upper extremities. Patients and Methods: A total of 12 patients underwent US-TPVB between the T2 and T3 paravertebral space with 10 mL of 1% mepivacaine. The temperature change (°C) before and after the procedure was compared between the ipsilateral and contralateral hands. We counted the proportion of patients showing a temperature increase ≥ 1.5°C and compared a change in the pain intensity before and after the procedure. Results: The median increase in the temperature change between the ipsilateral and contralateral hands was 1.54°C (interquartile range, 1.28– 2.20). There were seven patients (58.3%) who showed a temperature difference ≥ 1.5°C between both hands after the US-TPVB. Eleven patients (91.7%) reported a reduction in pain according to the score on the 11-point numerical rating scale. No serious complications relevant to the procedure were reported. Conclusion: US-TPVB could be a useful technique for sympathetic blockade in patients with upper extremity pain.

27 March 2026 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
HKHee Yong Kang
Hee Yong Kang
Chung Hun LeeChung Hun Lee
Chung Hun Lee
DKDoo-Hwan Kim
Doo-Hwan Kim
YKYeon-Dong Kim
Yeon-Dong Kim
WKWon-Joong Kim
Won-Joong Kim
SCSeong-Soo Choi
Seong-Soo Choi
Hee Yong Kang, Chung Hun Lee, Doo-Hwan Kim, Yeon-Dong Kim, Won-Joong Kim, Eunsoo Kim, Jae Hun Kim, Hyun Jung Kim, Yangki Minn, Kyungseung Yang, Jinyoung Oh, Yongjae Yoo, So Young Lim, Mihn-Sook Jue, Eun Joo Choi, Kunhee Han, and Seong-Soo Choi. Korean J Pain -0001;0:. https://doi.org/10.3344/kjp.25161

1 October 2019 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
HLHo-Jin Lee
Ho-Jin Lee
CLChang-Soon Lee
Chang-Soon Lee
YYYongjae Yoo
Yongjae Yoo
JNJae Mun Noh
Jae Mun Noh
JYJe Hyuk Yu
Je Hyuk Yu
JMJee Youn Moon
Jee Youn Moon
Ho-Jin Lee, Chang-Soon Lee, Yongjae Yoo, Jae Mun Noh, Je Hyuk Yu, Yong-Chul Kim, and Jee Youn Moon. Korean J Pain 2019;32:292-300. https://doi.org/10.3344/kjp.2019.32.4.292

6 June 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
YYYongjae Yoo
Yongjae Yoo
HRHyung Sang Row
Hyung Sang Row
JMJee Youn Moon
Jee Youn Moon
ECEun Joo Choi
Eun Joo Choi
FNFrancis Nahm
Francis Nahm
PLPyung-Bok Lee
Pyung-Bok Lee
Background: Spinal cord stimulation (SCS) is applied for managing chronic intractable pain, but the factors predicting its effectiveness have not been extensively researched. Our study aimed to identify clinical variables that can predict the outcome of SCS. Methods: The electronic medical records of patients who received SCS for chronic intractable pain at two large tertiary teaching institutions in South Korea from 2008 to 2022 were reviewed. A successful outcome was characterized by attaining at least a 50% reduction in pain on the numerical rating scale (NRS) assessed at 6 months. Multivariable analysis was used to investigate the correlation between outcomes of SCS and clinical variables. Results: Of the 213 patients, 108 (50.7%) experienced successful outcomes at 6 months after SCS implantation. At 6 months, both the positive and negative outcome groups had significantly lower NRS pain scores than at baseline. Multivariable analysis revealed that male gender (p = 0.023) was an independent predictor of positive SCS outcomes; conversely, longer pain duration (p = 0.011) was a negative predictor. No significant adverse events associated with SCS were observed throughout the six-month follow-up duration. Conclusions: SCS could be an effective treatment for chronic intractable pain, including complex regional pain syndrome (CRPS) and persistent spinal pain syndrome (PSPS). More successful outcomes may be expected in male patients with a shorter duration of pain. Additional research is required to enhance patient selection processes and to identify clinical characteristics that contribute to improved long-term outcomes.

18 June 2025 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
SNSeungpyo Nam
Seungpyo Nam
SLShiback Lee
Shiback Lee
SYSoo Hyuk Yoon
Soo Hyuk Yoon
HLHo-Jin Lee
Ho-Jin Lee
JMJee Youn Moon
Jee Youn Moon
JKJeongsoo Kim
Jeongsoo Kim
Seungpyo Nam, Shiback Lee, Soo Hyuk Yoon, Ho Jin Lee, Jee Youn Moon, Yongjae Yoo, and Jeongsoo Kim. Korean J Pain -0001;0:. https://doi.org/10.3344/kjp.24373